Everyone assumed safety-first AI labs were doomed until Dario Amodei left OpenAI in 2021 with his sister to launch Anthropic. They built Claude anyway, and the skepticism vanished fast. By May, the valuation hit $965B, then by October they were running an $81B revenue run-rate. Google and Nvidia each wrote checks totaling $10B to keep the momentum going. Then Amodei hit Wall Street with a timeline for disease that sounded wild. He stated cancer and Alzheimer's would become relics of the past in less than a decade. The pitch? An initial public offering set with a potential value up to $1.4 trillion under the ticker ANT. It is honestly insane how quickly the doubt turned into massive financial success.